ANOVA	analysis of variance
BC	breast cancer
DCIS	ductal carcinoma in situ
DFS	disease-free survival
DOX	doxycycline
DRI	drug-light interval
Hsp90	heat shock protein 90
H&E	hematoxylin and eosin
ICI	immune checkpoint inhibitors
IHC	immunohistochemistry
MIN	mammary intraepithelial neoplasia
nIR	near infrared
OS	overall survival
PDT	photodynamic therapy
PD-1	programmed cell death protein 1
PD-L1	programmed death-ligand 1
PMNs	polymorphonuclear leukocytes
PS	photosensitizer
ROS	reactive oxygen species
SCID	severe combined immunodeficiency
SEER	Surveillance, Epidemiology, and End Results
VP	verteporfin